CLiR No. 5 Cannabis. A new way to make science

Page 42

40

CANNABIS, THE CONTROVERSY UPDATED Guillermo Caletti, MD, PhD. Chief of Clinical Operations at Boehringer Ingelheim for Mexico and Central America.

It is interesting reading the great number of publications related to the use of Cannabis as a medicinal and recreational product and the worldwide controversy for the authorization, and regulation for its medicinal and recreational use. The history of Cannabis in Mexico is at least 5 centuries old, beginning with the introduction of hemp upon the arrival of Spaniards in the 16th century. Since then, hemp has had a continuous presence in Mexican society, economy, and national culture, either in the form of hemp products, as medicine for traditional use, and/or as a psychoactive substance. However, hemp had not been considered an unhealthy product until the 20th century, particularly during the ‘80s, when, due to pressure from the United States, the Mexican government was forced to start a fight against the Cannabis business, along with the illegal trade of cocaine from Colombia, increasing the levels of corruption within the government institutions, as well as the rise of organized crime and violence, linked to these unlawful businesses. Nevertheless, this national reaction had nothing to do with local problems of diseases related to the use of Cannabis, but rather to the Cannabis’ illegal trade in the United States and the flight of capital that this market represents. It should be noted that, according to the 2011 Annual Report of the United Nations Office on Drugs and Crime (UNODC), the United States has the highest annual consumption of marijuana (13.7%), while in Mexico, the consumption is barely 1%, only higher than in Ecuador (0.7%) and the Dominican Republic (0.3%). So, whose problem it is? From a health perspective, is marijuana a harmful substance? When a person learns that a relative or friend is consuming any type of drug,

| RESEARCH


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Use of cannabis as a potential treatment for Inflamatory Bowel Disease (IBD) - Dra. Ana Villaseñor-Todd

9min
pages 24-28

TETRAHIDROCANNABINOL (THC), GENETIC VARIABILITY AND VARIABILITY IN PHARMACOLOGICAL RESPONSE

8min
pages 52-55

ADVERSE FINANCIAL EVENTS CAN BE A SIGN OF DEMENTIA

1min
page 7

CHOCOLATE HEALTH CLAIMS

1min
page 7

PANDEMIC ADVERSE EVENTS: UNDERDIAGNOSIS OF OTHER DISEASES, THE CASE OF TUBERCULOSIS IN AMERICA

1min
page 6

DREXEL UNIVERSITY IN PHILADELPHIA OPENS MEDICAL CANNABIS RESEARCH CENTER

1min
page 6

Viola Brugnatelli: Scientific research, innovation, and awareness

2min
pages 62-64

"Chewing the soul” poem by Marco Antonio Gabriel

1min
page 65

How to smoke marijuana and have a good trip. A sociological look

5min
pages 60-61

Morphology and physiology between subspecies and sexes of Cannabis

12min
pages 36-41

Cannabis and technology: The new non-stigma of the 21st century. Mauro Orozco

3min
pages 57-59

The creative and inventive boom of Cannabis. Enrique U. Alcázar

7min
pages 46-56

Legal cannabinoid-based medicine in Mexico: challenges and perspectives

7min
pages 32-35

Cannabis in Latin America: the bloom of an industry under a new paradigm. Gerardo Garza Villarreal et al.

3min
pages 30-31

Cannabis, the controversy updated. Guillermo Caletti

5min
pages 42-45

Interview to Lorena Beltrán, one of the most prominent investigators and activists of Cannabis in Latin America

15min
pages 16-29

Does cannabis really have a medicinaluse? Why?

2min
pages 14-15

Cannabis old and new, risks and opportunities. Thor Nissen

3min
pages 11-12

Let us all build a solid industry! Israel Madrid

2min
page 9

EDITORIAL

2min
page 5

Our Cages. Dante Alducin

3min
page 13

Cannabis, beyond the myth. Marco A. Cid

2min
page 8

Cannabis’ new appraisal in Mexico. Midalia Denisse Arias

2min
page 10
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
CLiR No. 5 Cannabis. A new way to make science by Clinical Research Insider - Issuu